HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in CRPC

This study compared response to ketoconazole treatment among patients with castration-resistant prostate cancer who had 0, 1, or 2 HSD3B1 variant alleles.

http://ift.tt/2zBbyR8